Health Catalyst (HCAT) Return on Capital Employed (2019 - 2026)

Health Catalyst has reported Return on Capital Employed for 8 years, with the latest figure at 70.66% in Q1 2026.

• For the quarter ending Q1 2026, Return on Capital Employed fell 5812.0% year-over-year to 70.66%; the trailing twelve-month figure through Mar 2026 stood at 70.66% (down 5812.0% YoY), and the FY2025 full-year result was 27.21%, down 1185.0% from the prior year.
• Return on Capital Employed for Q1 2026 stood at 70.66%, down from 35.33% in the prior quarter.
• The five-year high for Return on Capital Employed was 12.54% in Q1 2025, with the low at 70.66% in Q1 2026.
• Historically, Return on Capital Employed has averaged 23.34% across 5 years, with a median of 20.52% in 2023.
• Annual changes were most pronounced in 2022 — Return on Capital Employed surged 1822 bps — and 2026, when it plunged 5812 bps.
• Health Catalyst's Return on Capital Employed stood at 20.54% in 2022, then increased by 0 bps to 20.52% in 2023, then soared by 33 bps to 13.68% in 2024, then plunged by 158 bps to 35.33% in 2025, then tumbled by 100 bps to 70.66% in 2026.
• The last three Return on Capital Employed figures came in at 70.66% (Q1 2026), 35.33% (Q4 2025), and 17.96% (Q3 2025), per Business Quant data.